Bacterial outer membrane protein vaccines: The meningococcal example

Advances in Experimental Medicine and Biology

Volumn 397, Issue , 1996, Pages 73-77

  Poolman, Jan T ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

BACTERIAL CELL WALL; CELLULAR IMMUNITY; CONFERENCE PAPER; EFFECTOR CELL; IMMUNE RESPONSE; IMMUNIZATION; MACROPHAGE ACTIVATION; MEMBRANE VESICLE; NEISSERIA MENINGITIDIS; NONHUMAN; OUTER MEMBRANE; PHAGOCYTOSIS; PRIORITY JOURNAL; VIRUS NEUTRALIZATION;

EID: 0030059237     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-1382-1_11     Document Type: Conference Paper

References (39)

1. Baehr, W, Zhang, Y. Z., Joseph, T., Su, H., Nano, F. E., Everett, K. D. E. Caldwell, H. D., 1988, Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane genes, Proc. Natl. Acad. Sci. USA, 85:4000-4004.
2. Bell, J., Grass, S., Jeanteur, D., Munson, R. S. jr., Diversity of the P2 protein among nontypeable Haemophilus influenzae isolates, Inf. Immun. 62:2639-2643.
3. Bjune, G., Høiby, E. A., Grønnesby, J. K., Arnesen, Ø., Fredriksen, J. H., Halstenen, A., Holten, E., Lindbak, A. K., Nøkleby, H., Rosenqvist, E, Solberg, L. K., Closs, O., Eng, J., Frøholm, L. O., Lystad, A., Bakketeig, L. S., Hareide, B., 1991, Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway, Lancet 338:1093-1096.
4. Brugghe, H. F., Timmermans, J. A. M., Van Unen, L. M. A., Ten Hove, G. J., Van de Werken, G., Poolman, J. T. and Hoogerhout, P., 1994, Simultaneous multiple synthesis and selective conjugation of head-to-tail cyclized peptides, derived from a surface-loop of a meningococcal class 1 outer membrane protein, Int. J. Pept. Prot. Res. 43:166-172.
5. Cassio de Moraes, J., Perkins, B.A., Camargo, M.C.C., Rossetto Hidaldo, N.T., Aparecida Barbosa, H., Tavares Sacchi, C., Landgraf, I. M., Gattas, V. L., Vascondcelos, H. de G., Plihaytis, B. D., Wenger, J. D., Broome, C. V., 1992, Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil, Lancet 340:1074-1078.
6. Christodoulides, M., McGuinness, B. T., Heckels, J. E., 1993, Immunization with synthetic peptides containing epitopes of the class 1 outer membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunization with a cyclic peptide, J. Gen. Microbiol. 139:1729-1738.
7. Christodoulides, M., Heckels, J.E., 1994, Immunization with a multiple antigen peptide containing defined B- and T-cell epitopes: production of bactericidal antibodies against group B Neisseria meningitidis, Microbiology 240:2951-2960.
8. Claassen, I., Meylis, J., Van der Ley, P., Peeters, C., Brons, H., Robert, J., Borsboom, D., Van der Ark, A., Van Straaten, I., Roholl, P., Kuipers, B., Poolman, J., Production, characterization and control of a hexavalent Class 1 Outer Membrane protein containing vesicle vaccine made from tailor-made Neisseria meningitidis strains, Vaccine submitted.
9. Conlan, J. W., Clarke, I. N., Ward, M. E., 1988, Epitope mapping with solid-phase peptides: identification of type-, subspecies-, species- and genus-reactive antibody binding domains on the major outer membrane protein of Chlamydia trachomatis, Mol. Microbiol. 2:673-679.
10. Cowan, S. W., Schirmer, T., Rummel, G., Steiert, M., Ghosh, R., Pauptit, R. A., Jansonius, J. N., Rosenbusch, J. P., 1992, Crystal structures explain functional properties of two E.coli porins, Nature, 358:727-733.
11. Fredriksen, J. H., Rosenqvist, E., Wedege, E., Bryn, K., Bjune, G., Frøholm, L. O., Lindbak, A. K., Møgster, B., Namork, E., Rye, U., Stabbetorp, G. Winsnes, R., Aase, B., Closs, O., 1991, Production, characterization and control of MenB-vaccine helsa: an outer membrane vesicle vaccine against group B meningococcal disease, NIPH annals 14:67-80.
12. Frontiers in medicine: Vaccines, 1994, Science 265:1371-1404.
13. Gilleland, H. E. jr., Parker, M. G., Matthews, J. M., Berg, R.D., 1984, Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice, Inf. Immun. 44:49-54.
14. Haase, E. M., Yi, K., Morse, G. D., Murphy, T. F., 1994, Mapping of bactericidal epitopes of the P2 porin protein of nontypeable Haemophilia influenzae, Inf. Immun. 62:3712-3722.
15. Helminen, M. E., Maciver, I., Latimer, J. L., Cope, L. D., McCracken, G. M. jr., Hansen, E. J., 1993, A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model, Inf. Immun. 61:2003-2010.
16. Hoogerhout P., Donders, E. M. L. M., Van Gaans-van den Brink, J. A. M., Kuipers, B, Brugghe, H. F., Van Unen, L. M. A., Timmermans, H., Ten Hove, G. J., De Jong, A. P. J. M., Peeters, C. C. A. M., Wiertz, E. J. H. J., Poolman, J. T., Conjugates of synthetic cyclic peptides elicit bactericidal antibodies against a conformational epitope on a class 1 outer membrane protein of Neisseria meningitidis, Inf. Immun. 63: 3473-3478.
17. Horwitz M. A., Lee, B. W. E., Dillon, B. J., Harth, G., 1995, Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis, Proc. Natl. Acad. Sci. USA 92:1530-1534.
18. Idänpään-Heikkilä, I., Muttilainen, S., Wahlström, Saarinen, L., Leinonen, M., Sarvas, M., Mäkelä, P. H., The antibody response to a prototype liposome vaccine containing Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis, Vaccine in press.
19. Isibasi, A., Ortiz-Navarrete, V., Paniagua, J., Pelayo, R., Gonzalez, C. R., Garcia, J. A., Kumate, J., 1992, Active protection of mice against Salmonella typhi by immunization with strain-specific porins, Vaccine 10:811-813.
20. Lissolo, L., Maitre-Wilmotte, G., Dumas, P., Mignon, M., Danve, B., Quenlin-Millet, M. J., 1995, Evaluation of transferrin-binding protein complex as a potential antigen for future meningococcal vaccines, Inf. Immun., 63:884-900.
21. Pettersson, A., Kuipers, B., Pelzer, M., Verhagen, E. P. M., Tiesjema, R. H., Tommassen, J., Poolman, J. T., 1990, Monoclonal antibodies against the 70-kilodalton iron-regulated protein of Neisseria meningitidis are bactericidal and strain-specific, Infect. Immun. 58:3036-3041.
22. Petterson, A., Van der Ley, P. A., Poolman, J. T., Tomassen, J., 1993, Molecular characterization of the 98kDa non-regulated outer membrane protein of Neisseria meningitidis, Inf.Immun. 61:4724-4733.
23. Poole, E., Lamont, I., 1992, Serovar differentiation of Chlamydia trachomatis by direct sequence analysis of the variable segment 4 region of the major outer membrane protein gene, Inf. Immun. 60:1089-1094.
24. Poolman, J. T., Hamstra, H. J., Barlow, A. K., Kuipers, A. J., Loggen, H., Nagel, J., 1990, Outer membrane vesicles of Bordetella pertussis are protective antigens in the mouse intracerebral challenge model. In: Manclark, C.R.(ed). Proc. VI International Pertussis Symposium, US Public Health Service, Bethesda, Maryland, DHHSPubl. no. (FDA)90-1164, pp 148-156.
25. Poolman, J. T., Van der Ley, P. A., Wiertz, E. J. H. J., Hoogerhout, P., 1991, Second generation meningococcal OMP-LPS vaccines, NIPH Annuals 14:233-241.
26. Poolman, J. T., 1995, Development of a meningococcal vaccine, Infect. Agents Dis. 4:13-28.
27. Poolman, J. T., Van der Ley, P. A., Tomassen, J., 1995, Surface structures and secreted products of meningococci, In: Meningococcal Disease, Publ. John Wiley & Sons, Ed. K. Cartwright: pp 21-34.
28. Rappuoli, R., Pizza, M., Podda, A., 1991, Towards third-generation whooping cough vaccines, Tibtech. 9:232-238.
29. Roy, S., Das, A. B., Ghosh, A. N., Biswas, T., 1994, Purification, pore-forming ability, and antigenic relatedness of the major outer membrane protein of Shigella dysenteride type 1, Inf. Immun. 62:433-4338.
30. Sikkema, D. J., Murphy, T. F., 1992, Molecular analysis of the P2 porin protein of nontypeable Haemophilus influenzae, Inf. Immun. 60:5204-5211.
31. Skrikumar, R., Dahan, D., Gras, M. F., Ratcliffe, M. J. H., van Alphen, L., Coulton, J. W., 1992, Antigenic sites on porin of Haemophilus influenzae type b: mapping with synthetic peptides and evaluation of structure presictions, J. Bacteriol. 174:4007-4016.
32. Sonntag, I., Schwartz, H., Hirota, Y., Henning, U., 1978, Cell envelope and shape of Escherichia coli: multiple mutants missing the outer membrane lipoprotein and other major outer membrane proteins, J. Bacteriol. 136:280-285.
33. Van der Ley, P. A., Heckels, J. E., Virji, M., Hoogerhout, P., Poolman J. T., 1991, Topology of outermembrane porins in pathogenic Neisseria spp, Infect. Immun. 59:2963-2971.
34. Van der Ley, P. A., Poolman, J. T., 1992, Construction of multivalent class 1 OMP expressing meningococcal vaccine strain, Infect. Immun. 60:3156-3161.
35. Van der Ley, P., Van der Biezen, J., Peeters, C. C. A. M., Poolman, J. T., 1993, Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis, Inf. Immun. 61:4724-4733.
36. Van der Ley, P. A., Van der Biezen, J., Poolman, J. T, 1995, Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine, Vaccine 13:401-407.
37. Wetzler, L. M., Blake, M. S., Barry, K., Gotschlich, E. C., 1992, Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants, J. Infect. Dis., 166:551-555.
38. Wiertz, E.J.H.J., Van Gaans-van den Brink, J.A.M., Gausephol, H., Prochnicka-Chalufour, A., Hoogerhout, P., Poolman, J.T., 1992, Identification of T cell epitopes occurring in a meningococcal class 1 outer membrane protein using overlapping peptides assembled with simultaneous multiple peptide synthesis, J. Exp. Med., 176:79-88.
39. Zhong, G., Berry, J., Brunham, R. C., 1994, Antibody recognition of a neutralization epitope on the major outer membrane protein of Chlamydia trachomatis, Inf. Immun. 62:1576-1583.